Skip to main content
Premium Trial:

Request an Annual Quote

Japan-based Softbank to Set Up $120 Million Life Science Fund

NEW YORK, Jan 26 – Tokyo-based Softbank plans to set up a $120 million fund to finance life science companies, a spokeswoman said Friday.

The fund will target companies in the US, Europe, and Asia, beginning in April or May.

Life science companies have much to gain from advances in information technology, said spokeswoman Misao Konishi, citing the role of computing power in the mapping of the human genome.

Softbank has not decided what percentage of the funds will go toward genomics businesses, Konishi said. The fund will invest in both start-ups and more mature companies.

Aozora Bank, which is also in Tokyo, will help finance the project, Konishi said, and other partners are expected to join as the project moves along.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.